Vext Science and Cannabis (VEXTF) Sells Prescott Cultivation Facility for $6.5 Million.
Vext Announces Consolidation of Arizona Cultivation Footprint to Drive Continued Profitability
Vext has signed a definitive agreement to sell...
Thumzup Media (TZUP) Ascends to Top 6.3% of All Active Reg A+ and Reg...
$1 Million Get's You in Top 10% of all Reg A's and Reg CF's?
LIVE QUOTE
Yuengling (YCRM) and PickleJar Announce Update to Complete Proposed Business Combination.
ATLANTA, GA, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Yuengling’s Ice Cream Corporation...
EyeOnChannel Production Studio & Network
Eye on Channel (EOC) is in its 7th year of operation. EOC is a digital video giant that connects millions of viewers...
Top Presenters, Dawson James 8th Annual Investor Conference.
..And The Winners Are.
The recent Dawson James 8th Annual Investor Conference was the bomb, with over 30 companies...
Vext Science (VEXTF) Signs Agreement to Acquire Two Additional Ohio Retail Cannabis Locations
Vext Agrees to Enter into Definitive Agreements to Acquire Two Additional Retail Locations in Ohio
Follows the previously...
New Financial Show from VYRE Networks (CAPV).
VBNGtv is proud to announce the talk show “The Avenue with Irina Sinclair”, Launching Nov 2023.
VYRE Business News Global...
Adding LQR House Beverages (LQR) to the Watch List
A Lot of Fast Moving Parts. A Lot of Studying to do.
Tempest Therapeutics’ (TPST) Stock Jumps 1,980%. $0.25 to $5.20
Yes, Good Things Can Happen in Phase I Folks!
OMG, That's $25,000 to $520,000. Party time. And yes Irene,...
Adding GeoVax (GOVX) $0.52 to Watch List.
Report Out Next Week. Head's Up.
Price and time-stamping our returning interest at $0.52.
We're...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
